An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE).

Saved in:
Bibliographic Details
Title: An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE).
Authors: Gaughan EE; Centre for Inflammation Research, Edinburgh BioQuarter.; Department of Respiratory Medicine., Quinn TM; Centre for Inflammation Research, Edinburgh BioQuarter.; Department of Respiratory Medicine., Mills A; Exploristics, Belfast, United Kingdom., Bruce AM; Centre for Inflammation Research, Edinburgh BioQuarter., Antonelli J; Centre for Inflammation Research, Edinburgh BioQuarter., MacKinnon AC; Galecto Inc., Copenhagen, Denmark; and., Aslanis V; Galecto Inc., Copenhagen, Denmark; and., Li F; Centre for Inflammation Research, Edinburgh BioQuarter., O'Connor R; Centre for Inflammation Research, Edinburgh BioQuarter., Boz C; Centre for Inflammation Research, Edinburgh BioQuarter., Mills R; Centre for Inflammation Research, Edinburgh BioQuarter., Emanuel P; Centre for Inflammation Research, Edinburgh BioQuarter., Burgess M; Centre for Inflammation Research, Edinburgh BioQuarter., Rinaldi G; Centre for Inflammation Research, Edinburgh BioQuarter., Valanciute A; Centre for Inflammation Research, Edinburgh BioQuarter., Mills B; Centre for Inflammation Research, Edinburgh BioQuarter., Scholefield E; Centre for Inflammation Research, Edinburgh BioQuarter., Hardisty G; Centre for Inflammation Research, Edinburgh BioQuarter., Findlay EG; Centre for Inflammation Research, Edinburgh BioQuarter., Parker RA; Edinburgh Clinical Trials Unit, Usher Institute, and., Norrie J; Edinburgh Clinical Trials Unit, Usher Institute, and., Dear JW; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom., Akram AR; Centre for Inflammation Research, Edinburgh BioQuarter.; Department of Respiratory Medicine., Koch O; Centre for Inflammation Research, Edinburgh BioQuarter.; Infectious Diseases Department, Western General Hospital, Edinburgh, United Kingdom., Templeton K; Department of Medical Microbiology, and., Dockrell DH; Centre for Inflammation Research, Edinburgh BioQuarter.; Infectious Diseases Department, Western General Hospital, Edinburgh, United Kingdom., Walsh TS; Centre for Inflammation Research, Edinburgh BioQuarter.; Department of Critical Care, New Royal Infirmary of Edinburgh, Edinburgh BioQuarter, Edinburgh, United Kingdom., Partridge S; Galecto Inc., Copenhagen, Denmark; and., Humphries D; Galecto Inc., Copenhagen, Denmark; and., Wang-Jairaj J; Galecto Inc., Copenhagen, Denmark; and., Slack RJ; Galecto Inc., Copenhagen, Denmark; and., Schambye H; Galecto Inc., Copenhagen, Denmark; and., Phung; Galecto Inc., Copenhagen, Denmark; and., Gravelle L; Galecto Inc., Copenhagen, Denmark; and., Lindmark B; Galecto Inc., Copenhagen, Denmark; and., Shankar-Hari M; Centre for Inflammation Research, Edinburgh BioQuarter.; Department of Critical Care, New Royal Infirmary of Edinburgh, Edinburgh BioQuarter, Edinburgh, United Kingdom., Hirani N; Centre for Inflammation Research, Edinburgh BioQuarter.; Department of Respiratory Medicine., Sethi T; Galecto Inc., Copenhagen, Denmark; and., Dhaliwal K; Centre for Inflammation Research, Edinburgh BioQuarter.; Department of Respiratory Medicine.
Source: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2023 Jan 15; Vol. 207 (2), pp. 138-149.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial
Journal Info: Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-4970
DOI:10.1164/rccm.202203-0477OC